Frontier Diagnostics, LLC
Smyrna, TN · Medtech · Defunct
MelanoMap™, a MALDI imaging mass spectrometry assay for melanoma diagnosis from skin biopsies
frontierdiagnostics.com →- Grants
- $3.2M
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 6
- 1 granted · 5 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201820192020
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · A Molecular Diagnostic Assay for Accurately Differentiating Melanoma from Benign Lesions | $299,244 | |
| Federal grant | Department of Health and Human Services · Phase II · A Molecular Diagnostic Assay for Accurately Differentiating Melanoma from Benign Lesions | $1,943,163 | |
| Federal grant | Department of Health and Human Services · Phase II · A Molecular Diagnostic Assay for Accurately Differentiating Melanoma from Benign Lesions | $944,492 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2275 | THERAPEUTIC BANDAGE PRODUCTS LLC | — | — |
| 2276 | CASCADE BIOSYSTEMS, INC. | — | — |
| 2277 | MASSACHUSETTS NEURO TECHNOLOGY, INC. | — | — |
| 2278 | Frontier Diagnostics, LLC | — | — |
| 2279 | GLYCODOTS, LLC | — | — |
| 2280 | GLOBAL BIOMEDICAL TECHNOLOGIES, LLC | — | $1.0M |
| 2281 | Celldom, Inc. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Imaging Mass Spectrometry And Uses Thereofapplication
- Imaging Mass Spectrometry And Uses Thereofgranted
- Mass Spectrometry Methods For Carcinoma Assessmentsapplication
- Mass Spectrometry Methods For Carcinoma Assessmentsapplication
- Imaging Mass Spectrometry And Uses Thereofapplication
- Mass Spectrometry Methods For Carcinoma Assessmentsapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.